GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sikarin PCL (BKK:SKR-R) » Definitions » Intrinsic Value: Projected FCF

Sikarin PCL (BKK:SKR-R) Intrinsic Value: Projected FCF : ฿7.78 (As of Jul. 05, 2025)


View and export this data going back to 1988. Start your Free Trial

What is Sikarin PCL Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2025-07-05), Sikarin PCL's Intrinsic Value: Projected FCF is ฿7.78. The stock price of Sikarin PCL is ฿6.894. Therefore, Sikarin PCL's Price-to-Intrinsic-Value-Projected-FCF of today is 0.9.

The historical rank and industry rank for Sikarin PCL's Intrinsic Value: Projected FCF or its related term are showing as below:

BKK:SKR-R' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.88   Med: 2.68   Max: 14.74
Current: 0.88

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Sikarin PCL was 14.74. The lowest was 0.88. And the median was 2.68.

BKK:SKR-R's Price-to-Projected-FCF is ranked better than
60.95% of 338 companies
in the Healthcare Providers & Services industry
Industry Median: 1.15 vs BKK:SKR-R: 0.88

Sikarin PCL Intrinsic Value: Projected FCF Historical Data

The historical data trend for Sikarin PCL's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sikarin PCL Intrinsic Value: Projected FCF Chart

Sikarin PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.23 4.85 6.11 6.93 7.48

Sikarin PCL Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.29 7.46 8.58 7.48 7.81

Competitive Comparison of Sikarin PCL's Intrinsic Value: Projected FCF

For the Medical Care Facilities subindustry, Sikarin PCL's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sikarin PCL's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sikarin PCL's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Sikarin PCL's Price-to-Projected-FCF falls into.


;
;

Sikarin PCL Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Sikarin PCL's Free Cash Flow(6 year avg) = ฿679.33.

Sikarin PCL's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Mar25)*0.8)/Shares Outstanding (Diluted Average)
=(14.362038579862*679.33104+7854.666*0.8)/2057.829
=7.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sikarin PCL  (BKK:SKR-R) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Sikarin PCL's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=6.894/7.7947737178247
=0.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sikarin PCL Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Sikarin PCL's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sikarin PCL Business Description

Traded in Other Exchanges
Address
976, Lasalle Road, Bangna Tai, Bangna, Bangkok, THA, 10260
Sikarin PCL is a Thailand-based company operating in the healthcare sector. It operates private hospitals located in eastern Bangkok, Samutprakarn Province and Hat Yai District, Songkhla Province namely Sikarin Hospital, Sikarin Samut Prakan Hospital, and Sikarin Hat Yai Hospital. Its services include general surgery services, obstetrics, aesthetic center, dental center, orthopedic center, checkup center, emergency and trauma center, and children center, among others.

Sikarin PCL Headlines

No Headlines